Article | Open

Herbicidal properties of antimalarial drugs

Published online:


The evolutionary relationship between plants and the malarial parasite Plasmodium falciparum is well established and underscored by the P. falciparum apicoplast, an essential chloroplast-like organelle. As a result of this relationship, studies have demonstrated that herbicides active against plants are also active against P. falciparum and thus could act as antimalarial drug leads. Here we show the converse is also true; many antimalarial compounds developed for human use are highly herbicidal. We found that human antimalarial drugs (e.g. sulfadiazine, sulfadoxine, pyrimethamine, cycloguanil) were lethal to the model plant Arabidopsis thaliana at similar concentrations to market herbicides glufosinate and glyphosate. Furthermore, the physicochemical properties of these herbicidal antimalarial compounds were similar to commercially used herbicides. The implications of this finding that many antimalarial compounds are herbicidal proffers two novel applications: (i) using the genetically tractable A. thaliana to reveal mode-of-action for understudied antimalarial drugs, and (ii) co-opting antimalarial compounds as a new source for much needed herbicide lead molecules.


Malaria is caused by protozoan endoparasites that belong to the genus Plasmodium and the phylum Apicomplexa with transmission between human hosts performed by female Anopheles mosquitoes. Interestingly, these protozoan parasites have much in common with plants1. The most obvious plant connection is that most apicomplexan parasites harbour a plastid similar to the chloroplast of plants and algae, known as the apicoplast. The origin of the apicoplast in Plasmodium and other apicomplexans is thought to be from secondary endosymbiosis whereby a heterotrophic eukaryote engulfed a red algal ancestor, the latter being retained as a plastid2,3,4,5. The apicoplast is non-photosynthetic, but critical for the survival of Plasmodium as it is involved in the synthesis of fatty acids, iron-sulphur clusters and haem, that are essential for the liver and mosquito stages of the parasite life cycle4,5,6,7. The production of isoprenoid precursors by the apicoplast is essential for the human blood stage8,9. In addition to this prominent chloroplast relic, many genes thought to have originated from the red algal ancestor have also transferred into the nuclear genome of apicomplexan parasites in a similar manner to chloroplast-encoded genes in plants10. Of note is that comparison of the P. falciparum genome with other annotated eukaryotic genomes revealed greater similarity of P. falciparum to the flowering plant Arabidopsis thaliana than any other non-apicomplexan taxa1.

A. thaliana was the first plant to have its genome sequenced11 and has become one of the most heavily studied model organisms in genetics and molecular biology. It is genetically tractable, has a small genome (135 MB, 5 chromosomes), a short life cycle and is easy to grow. A wealth of natural variants and gene knock-out lines are available as well as classical point mutants induced by mutagens such as ethyl methanesulfonate12.

The evolutionary relationship between apicomplexans and plants is not only apparent at the organelle level, but also from the activity of herbicides against Plasmodium. Indeed, pharmaceutical and agrochemical leads often show similarities in structure and activity13. Delaney et al.14 showed that the 20 most frequently used side chain groups in pharmaceutical drugs are found with similar frequency in herbicides. Coupled with this is that the target sites or biological processes that human drugs and agrochemicals interact with are sometimes shared. As such, compounds toxic to plants might similarly affect other organisms like Plasmodium species with examples available for commercial herbicides13. The widely used commercial herbicide glyphosate inhibits the P. falciparum asexual blood-stage in vitro, suggesting a shikimate pathway is shared with plants15. The commercial herbicide endothall inhibited growth of a chloroquine-sensitive P. falciparum strain with an IC50 of ≈8 μM16. Dinitroaniline-type herbicides also have activity against protozoal parasites including Plasmodium species17,18,19. In a larger study, the activity of 680 commercial agrochemicals including insecticides, fungicides and herbicides were systematically tested in vitro and in vivo on Plasmodium species, Leishmania species and trypanosomal parasites. Some of the compounds were highly active against protozoan pathogens and have potential as drug leads20.

Along with commercial herbicides, relationships between herbicidal and antimalarial compounds at the pre-development stage have also been reported in the literature. Witschel et al.21 investigated inhibitors of plant serine hydroxymethyltransferase, a key enzyme in the folate cycle, and showed many had significant activity against both P. falciparum and P. vivax enzymes. The antibiotic fosmidomycin which targets 1-deoxy-D-xylulose-5-phosphate reductoisomerase has been shown to be antimalarial22. Finally, the aryl bis-sulfonamides which are inhibitors of 2-methylerythritol 2,4-cyclodiphosphate synthase, were found to inhibit both A. thaliana and P. falciparum enzymes in vitro23.

Despite there being considerable interest in using herbicides as antimalarial compounds, applications in the reverse direction are lacking. Thus we explored this rationale, namely whether compounds specifically designed to kill Plasmodium and other apicomplexans are also active against plants. We found many antimalarial drugs to be herbicidal, which offers two new avenues for future research; the first and most obvious is to use the significant knowledge of antimalarial drugs to consider new chemistries or modes-of-action for herbicides. The second and more radical possibility is to use the genetically tractable A. thaliana to explore what could be shared modes-of-action for understudied antimalarial drugs.


The effect of herbicides on A. thaliana growth

To test the effect of compounds, sterile A. thaliana seeds were sown on media containing sugar, salts and vitamins, and supplemented with a compound of interest. After two weeks, the extent of growth inhibition for each compound was assessed by analysing images with ImageJ (Fig. 1). Most of the herbicides chosen (Table 1) inhibited A. thaliana germination and growth at 20 μg/mL (Fig. 2). Asulam inhibited growth after radicle emergence, whereas atrazine, glufosinate and glyphosate halted growth after expansion of what were chlorotic cotyledons. Atrazine was the only herbicide tested that displayed apparent instability, being less effective after one week of light (Supplementary Fig. 1). The concentration 20 μg/mL was sub-lethal for oryzalin and dicamba which across conditions inhibited growth by 76% and 64% respectively with arrested growth at the cotyledon stage. Trifluralin was less effective at 20 μg/mL, inhibiting growth by ≈50%. This is probably due to the well-known instability under sunlight and volatility of dinitroanilines24,25. Clethodim is a monocot-specific herbicide and inhibited A. thaliana (dicot) growth only by 3–30% and allowed true leaves to emerge (Supplementary Fig. 1). Overall these control compounds highlight that even successful market herbicides range in efficacy against A. thaliana and similarly, an antimalarial drug might not affect A. thaliana, but could remain highly effective against other, non-tested plant species.

Figure 1: Quantification of plant growth.
Figure 1

To quantify growth within a plate using ImageJ, an original image (i) was filtered using the ‘Threshold Colour’ plug-in so that only the shades of green are retained (ii) before the image was converted to an 8-bit image (iii) and threshold adjusted to convert grey shades into red pixels that are measurable by ImageJ (iv). In this way, from an image, the green pixels can be counted and a value for total area in mm2 obtained.

Table 1: Compounds tested in this study.
Figure 2: Growth of A. thaliana on media containing herbicides and antimalarials.
Figure 2

A. thaliana was raised from seeds on growth media containing 20 μg/mL of antimalarials and antibiotics (top row, middle row) in comparison to negative controls (DMSO, water) and known herbicides (bottom row). To test light and solution instability, media was pre-treated at 22 °C with light for 1 week (+light) or left at 4 °C in the dark for 1 week (+dark/cold) before sowing seeds. For each compound and condition, three replicates were done and a representative image is shown.

Antimalarial compounds with herbicidal activity

Of the twenty antimalarial compounds tested, (Table 1) eleven were active against A. thaliana at 20 μg/mL (Fig. 2). The artemisinin-based drugs artesunate and dihydroartemisinin (DHA) showed 98% growth inhibition and induced chlorosis in the cotyledons. Ciprofloxacin, clindamycin and methacycline allowed germination and full expansion of cotyledons that were completely white. Methacycline efficacy was reduced by light pre-treatment, but not dark pre-treatment, suggesting light sensitivity. Doxycycline, a tetracycline like methacycline, also induced chlorosis, but the plants yellowed rather than fully bleaching. Doxycycline showed some light sensitivity, but less than methacycline. The antifolates pyrimethamine, cycloguanil, sulfadoxine and sulfadiazine inhibited development allowing only emergence of the radicle. Dapsone, another antifolate, was effective under normal conditions, but was unstable showing reduced efficacy after light or dark pre-treatment of the medium, although the latter was not statistically significant at 95% confidence (P1 = 0.056). Amodiaquine, atovaquone, azithromycin, chloroquine, halofantrine, lumefantrine, mefloquine, piperaquine and primaquine did not have any herbicidal activity against A. thaliana at 20 μg/mL (Supplementary Fig. 1).

Calculating LD50 for herbicidal antimalarials

The antimalarial compounds that were stable and herbicidal at 20 μg/mL, were tested at a range of concentrations to determine potency alongside the herbicides glyphosate, glufosinate, asulam and atrazine as controls (Fig. 3A). Dose-response curves demonstrated a range of potencies (Fig. 3B,C) with the herbicides atrazine and asulam being the most potent compounds tested, with LD50 values of 0.19 μg/mL and 0.26 μg/mL, respectively. Of the eight antimalarial and antibiotic compounds tested here, the antibiotics ciprofloxacin (LD50 = 0.45 μg/mL) and clindamycin (LD50 = 0.9 μg/mL), and the antifolates sulfadiazine (LD50 = 0.86 μg/mL) and sulfadoxine (LD50 = 1.29 μg/mL) were the most herbicidal, notably with greater potency than glufosinate and glyphosate. The artemisinin derivate DHA was slightly more herbicidal than artesunate with LD50 values of 2.9 μg/mL and 5.0 μg/mL respectively. The antifolate cycloguanil (LD50 = 5.6 μg/mL) was of similar potency to pyrimethamine (LD50 = 7.1 μg/mL) and glyphosate (LD50 = 7.0 μg/mL). These data show some antimalarial compounds have similar or greater potency than the active ingredients of market herbicides.

Figure 3: Potency of herbicidal antimalarials.
Figure 3

(A) A. thaliana seeds raised on a concentration gradient of herbicides, antimalarials, and antibiotics. (B) Dose-response curves for all compounds, except DMSO. The X-axis is a log scale with concentrations tested. The Y-axis is given as percentage growth inhibition compared to DMSO control. Each data point is a mean value from six replicates (details in Supplementary Table 2). () Ciprofloxacin, (■) atrazine, () asulam, (×) sulfadiazine, (×) sulfadoxine, () clindamycin, (✚) glufosinate ammonium, (▬) artesunate, () cycloguani, () DHA, (□) glyphosate, and (▲) pyrimethamine. (C) LD50 (μg/mL) measured for all compounds.

The physicochemical properties of antimalarials vs herbicides

Although the physicochemical properties of herbicides and pharmaceuticals have much in common26, there are some consistent differences. Notably this includes the number of hydrogen bond donors, which in herbicides is rarely greater than one, whereas oral drugs can have up to five27. To determine whether the physicochemical properties of a specific antimalarial explains its herbicidal efficacy we subjected the tested compounds to a cluster analysis (Fig. 4) using an interactive database that compares and displays properties of 334 commercial herbicides26. In general, antimalarials have similar physicochemical properties to herbicides however compounds without herbicidal activity were often at the fringes, or outliers, when their physicochemical properties were mapped onto those of herbicides (Fig. 4). For example the larger compounds halofantrine, lumefantrine and piperaquine were outliers when polar surface area was plotted against molecular mass (Fig. 4D). Although their polar surface area is similar to herbicides with molecular masses of 150–400, compared to herbicides with molecular mass above 500, the polar surface area of these three compounds is exceptionally low. Methacycline and doxycycline, which were herbicidal but light sensitive, were outliers in graphs of polar surface area versus distribution coefficient (Fig. 4C) and polar surface area versus molar mass (Fig. 4D). In general though physicochemical properties alone could not explain the efficacy for some compounds. Another explanation is that some antimalarial modes-of-action will target processes that do not exist in plants (e.g. haem-binding by chloroquine).

Figure 4: Physicochemical properties of antimalarial compounds versus herbicides.
Figure 4

Representative charts (AC) were extracted using an interactive database containing the physicochemical properties of 334 commercial herbicides26. New data points (i.e. compounds studied here) were added to the database and plotted on graphs comparing two chemical properties, (A) molar mass vs lipophilicity (Log P), (B) molar mass vs aqueous solubility (Log S), (C) distribution coefficient (Log D) vs polar surface area (Å2) and (D) molar mass vs polar surface area (Å2). Cluster analyses show the general trends into which the antimalarial compounds fall. Black dots represent the antimalarial compounds that significantly inhibited plant growth, whereas solid grey dots represent antimalarial compounds with poor or no herbicidal activity. Transparent dots represent the 334 herbicidal compounds of the original database26.


The present study aimed to assess whether antimalarial compounds that have been historically used to treat malaria are also active as herbicides against plants. We tested twenty compounds ranging from highly specific antimalarial drugs to antimalarial antibiotics and of these, eleven were as potent or more potent than some commercial herbicides (Fig. 2, Supplementary Fig. 1). As plants and malarial parasites share a common evolutionary history, we believe that inhibitors of malarial cellular components might also be active against the orthologous components in plants. Such compounds could offer novel chemistries with new modes-of-action for the development of plant-specific inhibitors. Herbicide discovery has dramatically declined since the widely used herbicide glyphosate and glyphosate-resistant crops were implemented28. Just over twenty herbicide modes-of-action are known and no new mode-of-action has been used for herbicides released in the past two decades29. The importance of designing novel herbicidal chemistries is further underlined when looking at the alarming number of 252 weed species that have evolved resistance to one or more herbicidal mode-of-action. To glyphosate alone there are 269 reported cases of resistance in 27 countries from all over the globe30,31.

Inhibitors active against malarial parasites but showing only mild or no effect on plants can be explained by; (i) the active compound has no molecular targets in planta, (ii) the compound has a molecular target in planta, but interaction is prevented by physical barriers (e.g. root epidermis, leaf cuticle, lack of membrane transporters), (iii) the inhibitor has a target but is rapidly catabolised by the plant cell to be inactive.

The 4-aminoquinoline drugs chloroquine and amodiaquine have been widely used to prevent and treat malaria until resistant P. falciparum emerged32,33. In Arabidopsis, neither compound was herbicidal. The mechanism of action of chloroquine is well established, and the chemically similar amodiaquine is assumed to act in a similar fashion34. During haemoglobin catabolism, free haem is converted by Plasmodium into its insoluble and non-toxic form called haemozoin. Chloroquine binds to free haem, which prevents its conversion and the parasite becomes susceptible to haem toxicity35,36. Resistance to chloroquine is linked to mutations in membrane proteins of the parasite digestive vacuole37,38. Although the mode-of-action of mefloquine, halofantrine, piperaquine and lumefantrine remains unclear, evidence suggests that they also interfere with haemozoin formation39. As haemoglobin and the process of converting haem to haemozoin is absent in plants, this may explain the lack of herbicidal activity observed for all these compounds.

Primaquine is an important drug active in the liver stage of Plasmodium infections, mainly in P. vivax40. Its mechanism of action, although unclear, is thought to involve disruption of mitochondrial function41. It is suggested that primaquine metabolism in the body leads to the production of reactive intermediates and free radicals which account for its activity42. As primaquine showed no herbicidal activity against Arabidopsis and given that primaquine metabolism is required for its antimalarial activity, it is possible that primaquine is not metabolised in planta, thus remains inactive.

The macrolide antibiotic azithromycin is a semi-synthetic erythromycin derivative. Although it has activity against P. falciparum, especially in synergy with quinine43, azithromycin is a relatively weak antimalarial both in mono- and combination therapy44. In bacteria, azithromycin binds to the 50S ribosomal subunit and blocks transpeptidation and polypeptide translocation during translation, therefore inhibiting protein synthesis45. In vitro studies using Plasmodium species also showed that azithromycin could inhibit parasite invasion of red blood cells, a role independent of inhibition of protein synthesis46. In our study, azithromycin did not display herbicidal activity, possibly due to a lack of target. Alternatively, azithromycin might be able to target ribosomal functions in Arabidopsis as it does in bacteria, but lacks the required physicochemical properties to be active in plants (Fig. 4A,B and D).

Doxycycline and methacycline are broad-spectrum tetracycline antibiotics. In prokaryotes, tetracyclines block protein translation by binding to the ribosomal 30S subunit47. Although the mechanism of action for tetracyclines in Plasmodium remains unclear, doxycycline has been shown to act by disrupting the expression of apicoplast-encoded genes48. In Arabidopsis, doxycycline and methacycline induced bleaching of the cotyledons (Fig. 2). This might indicate that tetracyclines affect chloroplast function or have downstream effects on protein synthesis that leads to chlorophyll depletion. Although these compounds showed potential as herbicide leads, both compounds are light-sensitive, a downside of tetracycline antibiotics49. For obvious reasons, photo-sensitivity limits a compound being considered as an herbicidal lead.

Clindamycin is a semi-synthetic lincomycin derivative with antibiotic, antimalarial and anti-apicomplexan (e.g. Toxoplasma gondii) activities50. In prokaryotes, clindamycin binds the 50S ribosomal subunit and prevents interaction of peptidyl-tRNA with the ribosome, thereby inhibiting protein translation51. In protozoan parasites, clindamycin targets the apicoplast large rRNA subunit as inferred from clindamycin-resistant T. gondii mutants that harbour a point mutation in the apicoplast large rRNA subunit52. Clindamycin was revealed to be one of the most herbicidal compounds, with greater activity than glufosinate and glyphosate. Except for azithromycin, all inhibitors of protein synthesis tested here were herbicidal. Their mode-of-action in Arabidopsis could be similar to that in bacteria and protozoa. In terms of potency, ciprofloxacin, a quinolone-based antibiotic, was also more active than glufosinate and glyphosate in the plate assay (Fig. 4). It was recently shown that A. thaliana DNA gyrase, a type II topoisomerase, is the target of ciprofloxacin through the identification of a point mutation in the ATGYRA gene responsible for ciprofloxacin resistance in an A. thaliana genetic mutant53. Of the 20 known herbicide modes-of-action, DNA gyrase is not a current target of any market herbicide26, making the mode-of-action of ciprofloxacin an attractive avenue for the development of new herbicides.

Artesunate and dihydroartemisinin (DHA) are semi-synthetic derivatives of the antimalarial agent artemisinin, a natural product found in the Chinese herb Artemisia annua54. Artemisinin derivatives are the most widely used antimalarial drugs and are important components of artemisinin derivative-based combination therapies for the treatment of uncomplicated malaria55. The molecular mechanisms by which artemisinins act as antimalarials are still unclear and multiple modes-of-action have been proposed including interfering with iron-haem interactions and stimulating the formation of radical intermediates56,57, targeting of a calcium-ATPase transport protein, PfATP6 which affects calcium levels required for parasite invasion in red blood cells58 and interference in the formation of polyphosphorylated phosphoinositides, which are important regulators of signalling and trafficking functions in most eukaryotes59. Both artesunate and DHA were potent herbicides and although using such important compounds in an herbicidal context is unlikely, using A. thaliana as a model to gain insight into its mode-of-action might be sought.

The antifolates are important inhibitors of folate synthesis and metabolism. Folate and its derivatives are essential co-factors for DNA synthesis and production of several amino acids60. Of the enzymes involved in the folate pathway, dihydrofolate reductase (DHFR) and dihydropteroate synthase (DHPS) are well described as the molecular targets of important antifolate drugs. In both Plasmodium parasites and plants, DHFR is part of a bifunctional protein with thymidylate synthetase (DHFR-TS). Plant DHPS is also part of a bifunctional protein with hydroxymethylpterin pyrophoskinase (PPPK-DHPS)61. Pyrimethamine and cycloguanil inhibit P. falciparum DHFR-TS by binding DHFR62, whereas the sulfa-based drugs sulfadoxine, sulfadiazine and dapsone act by binding DHPS in bacteria and protozoans63,64. Here, all DHFR and DHPS inhibitors tested were herbicidal with dapsone the only compound that displayed photosensitivity. In addition all the compounds display good herbicidal physicochemical properties and as Arabidopsis and Plasmodium share the bifunctional-type DHFR and DHPS proteins, we expect the antifolate drugs tested here to have the same mode-of-action in plants and could present interesting starting points for new herbicidal development.

The mode-of-action for many antimalarials, some in use for decades, are unclear or unknown. As a result this prevents a greater understanding of the biological action of the compound and also prevents development of more potent compounds for the target. Some examples are the artemisinin-based compounds whose mode-of-action remains controversial and other, novel and promising antimalarial compounds whose modes-of-action remain to be investigated65. If the evolutionary relationship between Arabidopsis and Plasmodium is close enough that the antimalarial compounds have the same mode-of-action and same targets, the genetically tractable A. thaliana might have a place to study the biological action of these materials. Chemically mutagenized seeds could be sown and grown under drug selection to find resistant plants and map-based cloning of the resistance lesions could reveal the target or explain the compounds mode-of-action. Such a strategy has been employed by Jander et al.66 in the study of herbicide resistance where screens that used chlorsulfuron and imazethapyr found lesions in their target, acetolactate synthase, which is crucial for the biosynthesis of the branched-chain amino acids. Fluoroquinolones such as ciprofloxacin, are known topoisomerase inhibitors and have been shown to have potential as antimalarial compounds67. A mutagenesis strategy using A. thaliana seeds and screening for resistant plants found a genetic mutation in the equivalent plant target of ciprofloxacin, DNA gyrase A53 thus demonstrating the tractability of using A. thaliana to identify putative modes-of-action. Such a forward genetic approach using A. thaliana would not work for all antimalarial drugs, but would be very useful for protein targets where gene loss or single amino acid substitutions can render plants resistant to the compound.


Our study shows that compounds designed for treating malaria also display herbicidal activity. As antimalarial drugs are non-toxic to humans and display, in general, good physicochemical properties (e.g. water solubility) these make them attractive bioactive molecules. Due to the alarming recent increases in herbicide resistance, such compounds could offer a good starting point in the design of new herbicidal chemistries. Here we show that some antimalarials are as potent, or more potent, than the active components of commercial herbicides. From these observations, a few questions are raised; do all herbicidal antimalarials act in plants in similar ways as in malaria parasites, that is, do they inhibit similar proteins or affect the same pathways? If so, mutagenesis of the genetically tractable A. thaliana and screening for drug resistant plants could reveal the modes-of-action for understudied antimalarial drugs in the same way that forward genetics can reveal targets for herbicides. Another use of this cross-over concept is whether the significant resources that have become available for the development of antimalarial lead compounds could also be used to develop novel herbicides. The alarming rise globally in herbicide resistance in weeds30 is driving the agrochemical industry to search for new lead compounds and ideally, compounds with novel modes-of-action.


Germination assays

Arabidopsis thaliana ecotype Col-0 seeds were surface sterilised for 3 min in 70% ethanol, followed by 1 min in 100% ethanol and then soaked for 3 min in sterile water. Seeds were re-suspended in sterile 0.1% agar and incubated at 4 °C for 3 days to synchronise subsequent germination. Following this stratification treatment, seeds were sown on 96-well microplates (TrueLine, USA) with each well containing 0.25 mL of growth medium (1% agar, 1% glucose, 0.45% Murashige & Skoog salts with vitamins, 0.3% 2-(N-morpholino)-ethanesulfonic acid (MES) (v/v), pH 5.7) and the appropriate dose of DMSO, antimalarial, antibiotic or herbicide. Plates were sealed with porous tape and transferred to a chamber at 22 °C for two weeks under 16 h days and 60% relative humidity before a photo of each plate was taken. To initially determine the herbicidal nature of the antimalarial compounds, a screen using a single concentration was performed (20 μg/mL). If herbicidal activity was displayed, the assay was repeated with a range of concentrations. To investigate compound stability, plates were pre-treated for one week prior to seed sowing either by being left under lights at 22 °C or in the dark at 4 °C. Growth of seeds sown on these pre-treated plates were compared to seeds sown on freshly prepared plates.

Commercial herbicides, antimalarials and antibiotics

Twenty-eight compounds were tested for an herbicidal effect on A. thaliana. Eight commercially available herbicides were compared to twenty antimalarial compounds (Table 1). Amodiaquine, chloroquine, ciprofloxacin, glufosinate ammonium, glyphosate and oryzalin were obtained from Sigma-Aldrich. Artesunate was obtained from Pharbaco Central Pharmaceutical J.S.C., mefloquine from Roche, and asulam from Sapphire Bioscience. The rest (atovaquone, atrazine, azithromycin, clethodim, clindamycin, cycloguanil, dapsone, dicamba, dihydroartemisinin, doxycycline, halofantrine, lumefantrine, methacycline, piperaquine, primaquine, pyrimethamine, sulfadiazine, sulfadoxine, trifluralin) were sourced from AK Scientific. Stock solutions were prepared in DMSO, except chloroquine and glyphosate, which were prepared in water. Initial screening was at 20 μg/mL and the compounds that showed herbicidal activity were tested at a range of concentrations with DMSO as the negative control and four herbicides as positive controls.

Quantification of growth inhibition

To quantify growth inhibition on plates, photos were analysed using ImageJ (National Institutes of Health, 1.47 v). The ‘Threshold Colour’ plug-in was adjusted to specifically follow green pixels as a correlation of healthy seedlings, as opposed to chlorotic leaves which display pale yellow or white pixel characteristics. To display only green channels the settings ‘Hue’ was 50–110, ‘Saturation’ was 125–255 and ‘Brightness’ 30–255. Images were then converted into 8-bit format and the threshold adjusted to change the greyscale into red pixels that could be measured (ImageJ). Total green pixels were then compared to total well area (mm2) and data were normalised against the negative control (DMSO or water) to provide percentage inhibition.

Physicochemical properties of herbicidal compounds

The physicochemical properties of the tested compounds were calculated as described in Gandy et al.26 and displayed in the context of the physicochemical properties for 334 known herbicides.

Additional Information

How to cite this article: Corral, M. G. et al. Herbicidal properties of antimalarial drugs. Sci. Rep. 7, 45871; doi: 10.1038/srep45871 (2017).

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


  1. 1.

    et al. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419, 498–511 (2002).

  2. 2.

    , , & Nuclear-encoded, plastid-targeted genes suggest a single common origin for apicomplexan and dinoflagellate plastids. Mol. Biol. Evol. 18, 418–426 (2001).

  3. 3.

    , , , & A common red algal origin of the apicomplexan, dinoflagellate, and heterokont plastids. Proc. Natl. Acad. Sci. U.S.A. 107, 10949–10954 (2010).

  4. 4.

    The apicoplast. Protoplasma 248, 641–650 (2011).

  5. 5.

    & The algal past and parasite present of the apicoplast. Annu. Rev. Microbiol. 67, 271–289 (2013).

  6. 6.

    et al. Parasite plastids: maintenance and functions. Philos. Trans. R. Soc. Lond., B, Biol. Sci. 358, 155–164 (2003).

  7. 7.

    & The evolution, metabolism and functions of the apicoplast. Philos. Trans. R. Soc. Lond., B, Biol. Sci. 365, 749–763 (2010).

  8. 8.

    & Chemical rescue of malaria parasites lacking an apicoplast defines organelle function in blood-stage Plasmodium falciparum. PLoS Biol. 9, e1001138 (2011).

  9. 9.

    et al. Isoprenoid precursor biosynthesis is the essential metabolic role of the apicoplast during gametocytogenesis in Plasmodium falciparum. Eukaryot. Cell 14, 128–139 (2015).

  10. 10.

    , & Simple and complex nuclear loci created by newly transferred chloroplast DNA in tobacco. Proc. Natl. Acad. Sci. U.S.A. 101, 9710–9715 (2004).

  11. 11.

    The Arabidopsis Genome Initiative. Analysis of the genome sequence of the flowering plant Arabidopsis thaliana. Nature 408, 796–815 (2000).

  12. 12.

    et al. 50 years of Arabidopsis research: highlights and future directions. New Phytol. 209, 921–944 (2016).

  13. 13.

    Herbicide and pharmaceutical relationships. Weed Sci. 58, 334–339 (2010).

  14. 14.

    , , & Modern agrochemical research: a missed opportunity for drug discovery? Drug Discov. Today 11, 839–845 (2006).

  15. 15.

    et al. Evidence for the shikimate pathway in apicomplexan parasites. Nature 393, 801–805 (1998).

  16. 16.

    et al. A survey of synthetic and natural phytotoxic compounds and phytoalexins as potential antimalarial compounds. Biol. Pharm. Bull. 30, 1740–1744 (2007).

  17. 17.

    , , & Accumulation of the antimalarial microtubule inhibitors trifluralin and vinblastine by Plasmodium falciparum. Biochem. Pharmacol. 75, 1580–1587 (2008).

  18. 18.

    , , & Cellular and molecular actions of dinitroaniline and phosphorothioamidate herbicides on Plasmodium falciparum: Tubulin as a specific antimalarial target. Mol. Biochem. Parasitol. 145, 226–238 (2006).

  19. 19.

    et al. Antimitotic herbicides bind to an unidentified site on malarial parasite tubulin and block development of liver-stage Plasmodium parasites. Mol. Biochem. Parasitol. 188, 116–127 (2013).

  20. 20.

    , , & Agrochemicals against malaria, sleeping sickness, leishmaniasis and chagas disease. PLoS Negl. Trop. Dis. 6, e1805 (2012).

  21. 21.

    et al. Inhibitors of plasmodial serine hydroxymethyltransferase (SHMT): cocrystal structures of pyrazolopyrans with potent blood- and liver-stage activities. J. Med. Chem. 58, 3117–3130 (2015).

  22. 22.

    , , & Targeting the methyl erythritol phosphate (MEP) pathway for novel antimalarial, antibacterial and herbicidal drug discovery: inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase (DXR) enzyme. Curr. Pharm. Des. 13, 1161–1177 (2007).

  23. 23.

    et al. Aryl bis-sulfonamide inhibitors of IspF from Arabidopsis thaliana and Plasmodium falciparum. ChemMedChem 10, 2090–2098 (2015).

  24. 24.

    , & Volatilization of trifluralin, atrazine, metolachlor, chlorpyrifos, α-endosulfan, and β-endosulfan from freshly tilled soil. J. Agric. Food Chem. 50, 4009–4017 (2002).

  25. 25.

    , & Trifluralin photolysis in natural waters and under the presence of isolated organic matter and nitrate ions: kinetics and photoproduct analysis. J. Photochem. Photobiol. A Chem. 163, 473–480 (2004).

  26. 26.

    , , & An interactive database to explore herbicide physicochemical properties. Org. Biomol. Chem. 13, 5586–5590 (2015).

  27. 27.

    Selecting the right compounds for screening: does Lipinski’s Rule of 5 for pharmaceuticals apply to agrochemicals? Pest Manag. Sci. 57, 3–16 (2001).

  28. 28.

    Why have no new herbicide modes of action appeared in recent years? Pest Manag. Sci. 68, 505–512 (2012).

  29. 29.

    Current state of herbicides in herbicide-resistant crops. Pest Manag. Sci. 70, 1351–1357 (2014).

  30. 30.

    Global perspective of herbicide-resistant weeds. Pest Manag. Sci. 70, 1306–1315 (2014).

  31. 31.

    The International Survey of Herbicide Resistant Weeds, (2017).

  32. 32.

    & Chloroquine-resistant malaria. J. Infect. Dis. 184, 770–776 (2001).

  33. 33.

    , , , & 4-Aminoquinolines - past, present, and future; a chemical perspective. Pharmacol. Ther. 77, 29–58 (1998).

  34. 34.

    et al. Molecular modeling study of a series of amodiaquine analogues with antimalarial activity. Med. Chem. Res. 24, 3529–3536 (2015).

  35. 35.

    & The role of haem in the activity of chloroquine and related antimalarial drugs. Coord. Chem. Rev. 190–192, 493–517 (1999).

  36. 36.

    et al. An assessment of drug-haematin binding as a mechanism for inhibition of haematin polymerisation by quinoline antimalarials. Biochem. Pharmacol. 55, 727–736 (1998).

  37. 37.

    et al. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol. Cell 6, 861–871 (2000).

  38. 38.

    , & Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science 298, 210–213 (2002).

  39. 39.

    et al. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. The Lancet 364, 438–447 (2004).

  40. 40.

    , & Primaquine in vivax malaria: an update and review on management issues. Malaria. J. 10, 351 (2011).

  41. 41.

    Effect of the 8-aminoquinoline primaquine on culture-derived gametocytes of the malaria parasite Plasmodium falciparum. Parasitol. Res. 77, 478–481 (1991).

  42. 42.

    et al. The metabolism of primaquine to its active metabolite is dependent on CYP 2D6. Malaria. J. 12 (2013).

  43. 43.

    et al. Effective treatment of uncomplicated Plasmodium falciparum malaria with azithromycin-quinine combinations: a randomized, dose-ranging study. Am. J. Trop. Med. Hyg. 74, 401–406 (2006).

  44. 44.

    & Azithromycin for treating uncomplicated malaria. Cochrane Database Syst. Rev. (2011).

  45. 45.

    et al. In vitro efficacy, resistance selection, and structural modeling studies implicate the malarial parasite apicoplast as the target of azithromycin. J. Biol. Chem. 282, 2494–2504 (2007).

  46. 46.

    et al. Macrolides rapidly inhibit red blood cell invasion by the human malaria parasite, Plasmodium falciparum. BMC Biology 13, 52 (2015).

  47. 47.

    & Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol. Mol. Biol. Rev. 65, 232–260 (2001).

  48. 48.

    et al. Tetracyclines specifically target the apicoplast of the malaria parasite Plasmodium falciparum. Antimicrob. Agents Chemother. 50, 3124–3131 (2006).

  49. 49.

    , , & Tetracycline photolysis in natural waters: loss of antibacterial activity. Chemosphere 85, 1505–1510 (2011).

  50. 50.

    & Clindamycin as an antimalarial drug: review of clinical trials. Antimicrob. Agents Chemother. 46, 2315–2320 (2002).

  51. 51.

    , & The mechanism of action of macrolides, lincosamides and streptogramin B reveals the nascent peptide exit path in the ribosome. J. Mol. Biol. 330, 1005–1014 (2003).

  52. 52.

    , & An rRNA mutation identifies the apicoplast as the target for clindamycin in Toxoplasma gondii. Mol. Microbiol. 43, 1309–1318 (2002).

  53. 53.

    et al. DNA gyrase is the target for the quinolone drug ciprofloxacin in Arabidopsis thaliana. J. Biol. Chem. 291, 3136–3144 (2016).

  54. 54.

    , & Artemisinins. Postgrad. Med. J. 81, 71–78 (2005).

  55. 55.

    World Health Organisation Guidelines for the treatment of malaria, (2015).

  56. 56.

    et al. Oxidative stress in malaria parasite-infected erythrocytes: host–parasite interactions. Int. J. Parasitol. 34, 163–189 (2004).

  57. 57.

    , & Iron and heme metabolism in Plasmodium falciparum and the mechanism of action of artemisinins. Curr. Opin. Microbiol. 16, 722–727 (2013).

  58. 58.

    , , , & Pumped up: reflections on PfATP6 as the target for artemisinins. Trends Pharmacol. Sci. 35, 4–11 (2014).

  59. 59.

    , , , & PfPI3K, a phosphatidylinositol-3 kinase from Plasmodium falciparum, is exported to the host erythrocyte and is involved in hemoglobin trafficking. Blood 115, 2500–2507 (2010).

  60. 60.

    Exploring the folate pathway in Plasmodium falciparum. Acta Trop. 94, 191–206 (2005).

  61. 61.

    Mechanisms of resistance of Plasmodium falciparum to antimalarial drugs. Microbes Infect. 4, 165–174 (2002).

  62. 62.

    et al. Insights into antifolate resistance from malarial DHFR-TS structures. Nat. Struct. Biol. 10, 357–365 (2003).

  63. 63.

    Basis for antifolate action and resistance in malaria. Microbes Infect. 4, 175–182 (2002).

  64. 64.

    , , & Replacing sulfa drugs with novel DHPS inhibitors. Future Med. Chem. 5, 1331–1340 (2013).

  65. 65.

    et al. Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond. PLOS Pathogens 12, e1005763 (2016).

  66. 66.

    et al. Ethylmethanesulfonate saturation mutagenesis in Arabidopsis to determine frequency of herbicide resistance. Plant Physiol. 131, 139–146 (2003).

  67. 67.

    et al. Enhancement of the antimalarial activity of ciprofloxacin using a double prodrug/bioorganometallic approach. J. Med. Chem. 52, 7954–7957 (2009).

Download references


M.G.C. was supported by a University Postgraduate Award for International Students and a Scholarship for International Research by The University of Western Australia. J.S.M. and K.A.S. acknowledge the Australian Research Council (ARC) Future Fellowship program for support (FT120100013 and FT100100291, respectively).

Author information


  1. School of Molecular Sciences, The University of Western Australia, 35 Stirling Highway, Crawley, Perth 6009, Australia

    • Maxime G. Corral
    • , Julie Leroux
    • , Keith A. Stubbs
    •  & Joshua S. Mylne
  2. The ARC Centre of Excellence in Plant Energy Biology, 35 Stirling Highway, Crawley, Perth 6009, Australia

    • Maxime G. Corral
    • , Julie Leroux
    •  & Joshua S. Mylne


  1. Search for Maxime G. Corral in:

  2. Search for Julie Leroux in:

  3. Search for Keith A. Stubbs in:

  4. Search for Joshua S. Mylne in:


J.S.M. conceived the study. M.G.C., J.L. and J.S.M. performed the experiments. M.G.C., J.S.M. and K.A.S. analyzed the data. M.G.C. and J.S.M. wrote the manuscript with help from K.A.S.

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Joshua S. Mylne.

Supplementary information


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit